Ordaōs Bio

Ordaos Bio’s lab-in-the-loop AI platform designs novel biologics, validated by successful projects with top pharma. Their 5-day "lab-in-the-loop" cycle promises better drugs to patients faster and more reliably than alternatives. With $40M+ in near-term license potential, they are raising a $7M bridge to advance lead assets through in vivo studies.